Medicus Pharma Ltd. (MDCXW) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 7.28M | 7.14M | 9.78M | 11M | 5.09M | 5.38M | 5.44M | 8.48M | 654.48K | 1.89M | 5.11M | 154.35K |
| Cash & Short-Term Investments | 6.37M | 6.35M | 8.66M | 9.67M | 3.98M | 4.16M | 5.31M | 2.94M | 542.4K | 1.72M | 5.11M | 146.57K |
| Cash Only | 6.37M | 6.35M | 8.66M | 9.67M | 3.98M | 4.16M | 5.31M | 2.94M | 542.4K | 1.72M | 5.11M | 146.57K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 916.96K | 792.36K | 1.12M | 375.81K | 0 | 0 | 0 | 5.47M | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 144.33K | 197K | 196.25K | 937.9K | 570.09K | 268.57K | 278.39K | 304.71K | 330.75K | 0 | 0 | 0 |
| Property, Plant & Equipment | 144.33K | 124.55K | 196.25K | 221K | 245.09K | 268.57K | 278.39K | 304.71K | 330.75K | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 72.45K | 0 | 716.9K | 325K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 7.43M | 7.34M | 9.98M | 11.93M | 5.66M | 5.65M | 5.72M | 8.78M | 985.23K | 1.89M | 5.11M | 154.35K |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 31.27% | 29.98% | 74.41% | 35.91% | 474.27% | 198.29% | 12% | 5589.24% | - | - | - | - |
| Total Current Liabilities | 5.95M | 7.25M | 10.66M | 8.54M | 3.34M | 2.31M | 1.99M | 2.06M | 1.3M | 781.61K | 1.6M | 13.32M |
| Accounts Payable | 2.28M | 0 | 2.03M | 1.77M | 2.04M | 1.28M | 1.88M | 0 | 0 | 210.84K | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | 6.57K | - | - | - | - | - |
| Short-Term Debt | 145.46K | 3.93M | 141.07K | 4.7M | 118.22K | 116.32K | 0 | 0 | 0 | 0 | 0 | 2.35M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.53M | 3.1M | 8.49M | 421.29K | 0 | 140.99K | 0 | 1.95M | 1.23M | 27.77K | 1.6M | 10.97M |
| Current Ratio | 1.22x | 0.99x | 0.92x | 1.29x | 1.53x | 2.33x | 2.73x | 4.11x | 0.50x | 2.42x | 3.19x | 0.01x |
| Quick Ratio | 1.22x | 0.99x | 0.92x | 1.29x | 1.53x | 2.33x | 2.73x | 4.11x | 0.50x | 2.42x | 3.19x | 0.01x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 45.21K | 62.74K | 124.65K | 141.75K | 174.4K | 205.94K | 236.58K | 266.48K | 294.67K | 0 | 0 | 0 |
| Long-Term Debt | 24.17K | 18.87K | 95.19K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 43.87K | 0 | 141.75K | 174.4K | 205.82K | 236.58K | 266.48K | 294.67K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 21.04K | 0 | 29.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 6M | 7.31M | 10.78M | 8.69M | 3.51M | 2.51M | 2.23M | 2.33M | 1.6M | 781.61K | 1.6M | 13.32M |
| Total Debt | 169.62K | 4M | 236.26K | 4.97M | 412.91K | 322.27K | 348.97K | 375.03K | 365.79K | 0 | 0 | 2.35M |
| Net Debt | -6.2M | -2.36M | -8.43M | -4.7M | -3.57M | -3.84M | -4.96M | -2.56M | -176.61K | -1.72M | -5.11M | 2.21M |
| Debt / Equity | 0.12x | 146.80x | - | 1.53x | 0.19x | 0.10x | 0.10x | 0.06x | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -16.73x | -39.82x | - | - | - | -1.86x | -328.42x | -45.79x | -197.88x | - | -8.67x | -1.02x |
| Total Equity | 1.43M | 27.22K | -804.89K | 3.25M | 2.15M | 3.13M | 3.49M | 6.45M | -610.25K | 1.11M | 3.51M | -13.17M |
| Equity Growth % | -33.51% | -99.13% | -123.05% | -49.64% | 451.92% | 182.04% | -0.42% | 148.98% | - | - | - | - |
| Book Value per Share | 0.05 | 0.00 | -0.04 | 0.23 | 0.18 | 0.33 | 0.37 | 0.79 | -0.08 | 0.55 | 0.70 | -1.64 |
| Total Shareholders' Equity | 1.33M | -49.28K | -910.13K | 3.25M | 2.15M | 3.13M | 3.49M | 6.45M | -610.25K | 1.11M | 3.51M | -13.17M |
| Common Stock | 67.11M | 41.64M | 48.48M | 37.83M | 32.91M | 30.52M | 30.52M | 30.52M | 19.84M | 18.76M | 19.84M | 194.54K |
| Retained Earnings | -73.39M | -46.94M | -56.16M | -40.18M | -34.01M | -28.9M | -27.75M | -24.79M | -20.66M | -17.75M | -16.33M | -13.37M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -190.51K | 236.96K | 10.68K | 0 | 0 | 0 | 727.3K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 101.84K | 76.5K | 105.24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |